137 related articles for article (PubMed ID: 38551152)
1. Canagliflozin or acarbose versus placebo to ameliorate post-bariatric hypoglycaemia - The HypoBar I randomized clinical trial protocol.
Lobato CB; Winding CT; Bojsen-Møller KN; Martinussen C; Veedfald S; Holst JJ; Madsbad S; Jørgensen NB; Dirksen C
Diabet Med; 2024 Jun; 41(6):e15320. PubMed ID: 38551152
[TBL] [Abstract][Full Text] [Related]
2. Study protocol for a randomised, double-blind, placebo-controlled crossover trial assessing the impact of the SGLT2 inhibitor empagliflozin on postprandial hypoglycaemia after gastric bypass.
Ferreira A; Emara AFA; Herzig D; Melmer A; Vogt AP; Nakas CT; Facchinetti A; Dalla Man C; Bally L
BMJ Open; 2022 Sep; 12(9):e060668. PubMed ID: 36123073
[TBL] [Abstract][Full Text] [Related]
3. Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide.
Øhrstrøm CC; Worm D; Højager A; Andersen D; Holst JJ; Kielgast UL; Hansen DL
Diabetes Obes Metab; 2019 Sep; 21(9):2142-2151. PubMed ID: 31144430
[TBL] [Abstract][Full Text] [Related]
4. Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass.
Øhrstrøm CC; Worm D; Kielgast UL; Holst JJ; Hansen DL
Obes Surg; 2020 Mar; 30(3):1038-1045. PubMed ID: 31907828
[TBL] [Abstract][Full Text] [Related]
5. Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass.
Ferreira A; Schönenberger KA; Potoczna N; Vogt A; Gerber PA; Zehetner J; Giachino D; Nett P; Gawinecka J; Cossu L; Fuster DG; Dalla Man C; Facchinetti A; Melmer A; Nakas CT; Hepprich M; Donath MY; Herzig D; Bally L
Diabetes Technol Ther; 2023 Jul; 25(7):467-475. PubMed ID: 37093196
[No Abstract] [Full Text] [Related]
6. Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.
Craig CM; Liu LF; Deacon CF; Holst JJ; McLaughlin TL
Diabetologia; 2017 Mar; 60(3):531-540. PubMed ID: 27975209
[TBL] [Abstract][Full Text] [Related]
7. A Potential Role for Endogenous Glucagon in Preventing Post-Bariatric Hypoglycemia.
Lobato CB; Pereira SS; Guimarães M; Hartmann B; Wewer Albrechtsen NJ; Hilsted L; Holst JJ; Nora M; Monteiro MP
Front Endocrinol (Lausanne); 2020; 11():608248. PubMed ID: 33424773
[TBL] [Abstract][Full Text] [Related]
8. Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia.
Mulla CM; Goldfine AB; Dreyfuss JM; Houten S; Pan H; Pober DM; Wewer Albrechtsen NJ; Svane MS; Schmidt JB; Holst JJ; Craig CM; McLaughlin TL; Patti ME
Obes Surg; 2019 Jul; 29(7):2092-2099. PubMed ID: 30976983
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Hormonal Response to a Mixed-Meal Challenge in Hypoglycemia After Sleeve Gastrectomy vs Gastric Bypass.
Lee CJ; Clark JM; Egan JM; Carlson OD; Schweitzer M; Langan S; Brown T
J Clin Endocrinol Metab; 2022 Sep; 107(10):e4159-e4166. PubMed ID: 35914520
[TBL] [Abstract][Full Text] [Related]
10. Glycemic Patterns Are Distinct in Post-Bariatric Hypoglycemia After Gastric Bypass (PBH-RYGB).
Lee D; Dreyfuss JM; Sheehan A; Puleio A; Mulla CM; Patti ME
J Clin Endocrinol Metab; 2021 Jul; 106(8):2291-2303. PubMed ID: 33974064
[TBL] [Abstract][Full Text] [Related]
11. Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels.
Valderas JP; Ahuad J; Rubio L; Escalona M; Pollak F; Maiz A
Obes Surg; 2012 Apr; 22(4):582-6. PubMed ID: 22161170
[TBL] [Abstract][Full Text] [Related]
12. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
Martinussen C; Veedfald S; Dirksen C; Bojsen-Møller KN; Svane MS; Wewer Albrechtsen NJ; van Hall G; Kristiansen VB; Fenger M; Holst JJ; Madsbad S
Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E956-E964. PubMed ID: 32182123
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Post-gastrectomy reactive hyperinsulinemic hypoglicaemia: glucose trends before and after canagliflozin treatment.
Bellastella G; Caruso P; Carbone C; di Nuzzo M; Scappaticcio L; Paglionico VA; Maiorino MI; Esposito K
Front Endocrinol (Lausanne); 2023; 14():1193696. PubMed ID: 37645417
[TBL] [Abstract][Full Text] [Related]
14. Nutritional strategies for correcting low glucose values in patients with postbariatric hypoglycaemia: A randomized controlled three-arm crossover trial.
Schönenberger KA; Ferreira A; Stebler C; Prendin F; Gawinecka J; Nakas CT; Mühlebach S; Stanga Z; Facchinetti A; Herzig D; Bally L
Diabetes Obes Metab; 2023 Oct; 25(10):2853-2861. PubMed ID: 37336721
[TBL] [Abstract][Full Text] [Related]
15. Canagliflozin in Conjunction With Sulfonylurea Maintains Glycemic Control and Weight Loss Over 52 Weeks: A Randomized, Controlled Trial in Patients With Type 2 Diabetes Mellitus.
Yale JF; Xie J; Sherman SE; Garceau C
Clin Ther; 2017 Nov; 39(11):2230-2242.e2. PubMed ID: 29103664
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycaemia.
Craig CM; Liu LF; Nguyen T; Price C; Bingham J; McLaughlin TL
Diabetes Obes Metab; 2018 Feb; 20(2):352-361. PubMed ID: 28776922
[TBL] [Abstract][Full Text] [Related]
17. Dasiglucagon Effectively Mitigates Postbariatric Postprandial Hypoglycemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Nielsen CK; Øhrstrøm CC; Kielgast UL; Hansen DL; Hartmann B; Holst JJ; Lund A; Vilsbøll T; Knop FK
Diabetes Care; 2022 Jun; 45(6):1476-1481. PubMed ID: 35320361
[TBL] [Abstract][Full Text] [Related]
18. Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis.
Pfeifer M; Townsend RR; Davies MJ; Vijapurkar U; Ren J
Cardiovasc Diabetol; 2017 Feb; 16(1):29. PubMed ID: 28241822
[TBL] [Abstract][Full Text] [Related]
19. Rate of post-bariatric hypoglycemia using continuous glucose monitoring: A meta-analysis of literature studies.
Lupoli R; Lembo E; Rainone C; Schiavo L; Iannelli A; Di Minno MND; Capaldo B
Nutr Metab Cardiovasc Dis; 2022 Jan; 32(1):32-39. PubMed ID: 34802853
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of acarbose and dietary modifications to limit glycemic variability following Roux-en-Y gastric bypass as assessed by continuous glucose monitoring.
Ritz P; Vaurs C; Bertrand M; Anduze Y; Guillaume E; Hanaire H
Diabetes Technol Ther; 2012 Aug; 14(8):736-40. PubMed ID: 22853724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
